Table 3 Incidence of events in each group.

From: Escalation of liPid-lOwering therapy in patientS wiTh vascular disease receiving HIGH-intensity statins: the retrospective POST-HIGH study

 

Number of events (events/100 person-year)

HR (95% CI)

p

Escalation

(n = 164)

Control

(n = 328)

MACCE

6 (1.72)

33 (3.38)

0.34 (0.14, 0.83)

0.018

Cardiovascular death

0 (0)

1 (0.10)

–

–

Myocardial infarction

0 (0)

4 (0.41)

–

–

PCI

5 (1.43)

24 (2.46)

0.41 (0.15, 1.08)

0.070

CABG

1 (0.29)

0 (0)

–

–

Ischaemic stroke

0 (0)

4 (0.41)

–

–

All-cause death

3 (0.86)

10 (1.02)

0.58 (0.15, 2.19)

0.42

  1. HR, hazard ratio; CI, confidence interval; MACCE, major adverse cardiovascular and cerebrovascular events; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft.
Back to article page